Cogent Biosciences, Inc.
Ticker: 1622229
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2020 | Q2 FY2020 |
|---|---|---|
| INCOME | ||
| Revenue | 0.31-41.5% | 0.53 |
| Total Income | 0.31-41.5% | 0.53 |
| EXPENSES | ||
| Expenditure | 57.51+625.2% | 7.93 |
| PROFIT | ||
| Net Profit | -49.98-576.3% | -7.39 |
| KEY METRICS | ||
| OPM % | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% |
Corporate Events
Board MeetingCOGT
20269Jun
Board Meeting
2026 Annual Meeting of Stockholders to vote on the election …
SEC Filing ↗